Vitamin D and SARS-CoV-2 virus/COVID-19 disease by Lanham-New, Susan A et al.
1Lanham- New SA, et al. bmjnph 2020;0. doi:10.1136/bmjnph-2020-000089
Open access 
Vitamin D and SARS- CoV-2 virus/
COVID-19 disease
Susan A Lanham- New,1 Ann R Webb,2 Kevin D Cashman,3 Judy L Buttriss,4 
Joanne L Fallowfield,5 Tash Masud,6 Martin Hewison,7 John C Mathers,8 
Mairead Kiely,3 Ailsa A Welch,9 Kate A Ward,10 Pamela Magee,11 Andrea L Darling,1 
Tom R Hill,8 Carolyn Greig,12 Colin P Smith,13 Richard Murphy,14 Sarah Leyland,15 
Roger Bouillon,16 Sumantra Ray,11,17,18 Martin Kohlmeier  18,19
To cite: Lanham- New SA, 
Webb AR, Cashman KD, et al.  
Vitamin D and SARS- CoV-2 
virus/COVID-19 disease. 
BMJ Nutrition, Prevention & 
Health 2020;0. doi:10.1136/
bmjnph-2020-000089
For numbered affiliations see 
end of article.
Correspondence to
Professor Susan A Lanham- New, 
Nutritional Sciences, University 
of Surrey Faculty of Health and 
Medical Sciences, Guildford GU2 
7XH, UK;  
 s. lanham- new@ surrey. ac. uk
Received 16 April 2020
Revised 29 April 2020
Accepted 30 April 2020
Brief report
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
BaCkground and aim
The spread of novel SARS- CoV-2 virus, and 
the disease COVID-19 that is caused by 
SARS- CoV-2, continues apace. Saving lives 
and slowing the worldwide pandemic remain 
of utmost importance to everyone: the public, 
healthcare professionals, scientists, industry 
and governments.
It is absolutely essential that advice given 
to the public is evidence- based, accurate and 
timely; anything less would mislead and has 
the potential to cause harm. Popular infor-
mation channels, such as social media plat-
forms, have been rife with misinformation 
that has been perpetuated by fear and uncer-
tainty. This has been the case particularly for 
diet and lifestyle advice. There are recom-
mendations for the prevention of the spread 
of COVID-19 from the WHO,1 the UK,2 Irish3 
and USA4 governments and the European 
Commission,5 as well as public health and 
healthcare agencies, including key direction 
on self- isolation.6
This short original report aims to provide 
a balanced scientific view on vitamin D and 
SARS- CoV-2 virus/COVID-19 disease. It 
provides a succinct summary of the current 
scientific evidence of associations between 
vitamin D, influenza, upper respiratory tract 
infections (URTIs) and immune health. 
Importantly, the paper concludes with life-
style strategies for avoiding vitamin D defi-
ciency and ensuring a healthy balanced diet 
at any time, including during the current 
pandemic. The overarching messages are as 
follows: (1) Vitamin D is essential for good 
health. (2) Many people, particularly those 
living in northern latitudes (such as the UK, 
Ireland, Northern Europe, Canada and the 
northern parts of the USA, northern India 
and China), have poor vitamin D status, espe-
cially in winter or if confined indoors. (3) Low 
vitamin D status may be exacerbated during 
this COVID-19 crisis (eg, due to indoor 
living and hence reduced sun exposure), 
and anyone who is self- isolating with limited 
access to sunlight is advised to take a vitamin D 
supplement according to their government’s 
recommendations for the general popula-
tion (ie, 400 IU/day for the UK7 and 600 IU/
day for the USA (800 IU for >70 years))8 
and the European Union (EU).9 (4) There 
is no strong scientific evidence to show that 
very high intakes (ie, mega supplements) of 
vitamin D will be beneficial in preventing or 
treating COVID-19. (5) There are evidenced 
health risks with excessive vitamin D intakes 
especially for those with other health issues 
such as a reduced kidney function.
nuTriTion, viTamin d and immuniTy
Good nutrition and lifestyle factors (such 
as physical activity) have a positive impact 
on immune function, promoting biological 
and physiological systems and processes that 
enable humans to resist infection. In light of 
the current COVID-19 pandemic, and given 
the importance of diet to overall health and 
well- being, nutrients (macro and micro) 
deserve special attention.10 As a key micronu-
trient, vitamin D should be given particular 
focus—not as a ‘magic bullet’ to beat COVID-
19, as the scientific evidence base is severely 
lacking at this time—but rather as part of a 
healthy lifestyle strategy to ensure that popu-
lations are nutritionally in the best possible 
place.11
Vitamin D is unique: it is a prohormone 
which is produced in the skin during exposure 
to sunlight (UVB radiation at 290–315 nm) 
with, usually, smaller amounts obtained from 
food. During the winter months in areas of 
middle- high latitude, the solar elevation 
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remains low throughout the short daylight period, and 
there is insufficient solar UVB to support appreciable 
vitamin D synthesis.12 For most people, dietary intake 
does not fully supply the body’s vitamin D needs and so 
vitamin D status declines during the winter. For example, 
in Manchester, UK (53.5N) the nadir of seasonal vitamin 
D status occurs in February, with sunlight exposure once 
again becoming effective for vitamin D synthesis in the 
skin only from March onwards.13 Relatively high preva-
lence of low vitamin D status globally has been reported 
over recent decades in a wide range of population 
groups,14 including those in low latitude areas (despite 
the abundance of sunlight) and not necessarily confined 
to winter.15 This may be due to environmental factors, 
such as air pollution, as well as cultural factors that lead 
to skin being covered and not subject to sunlight expo-
sure.16 Older, housebound individuals are at particularly 
high risk of vitamin D deficiency.17
Vitamin D status is reflected by the level of the circu-
lating metabolite 25- hydroxyvitamin D (25OHD), which 
is produced by hepatic hydroxylation of vitamin D 
coming from either skin or the gut from oral intake.18 If 
the 25OHD concentration is low (as defined in the UK by 
a 25OHD concentration of <25 nmol/L7 and in the USA 
and some other countries by a 25OHD concentration of 
<30 nmol/L),8 9 such as observed commonly during and 
towards the end of the winter, this indicates that stores 
are depleted and vitamin D- requiring functions may be 
impaired. The association between low vitamin D status 
and increased risk of rickets in children and poor muscu-
loskeletal health in adults is well documented. In addi-
tion, vitamin D, via its active metabolites, regulates more 
than 200 genes including those genes that are responsible 
for cellular proliferation, differentiation and apoptosis.19 
The discovery of the expression of nuclear vitamin D 
receptors and vitamin D metabolic enzymes in immune 
cells provides a scientific rationale for the potential role 
of vitamin D in maintaining immune homoeostasis and in 
preventing the development of autoimmune processes.20 
The field of vitamin D research has grown exponentially 
in recent years with a much improved understanding 
of its biological importance. Recent meta- analyses of 
randomised controlled trials (RCTs) concluded that the 
use of vitamin D supplements was associated with lower 
total mortality in elderly, mostly vitamin D- deficient 
participants.21 22 However, the most recent Vitamin D 
Assessment Study and the Vitamin D and Omega-3 Fatty 
Acid Study did not show a mortality effect in vitamin D- re-
plete adults.23 24
viTamin d and respiraTory healTh
It has been hypothesised that there is an association 
between seasonal URTIs and low vitamin D status because 
both occur in the winter months. However, controversy 
remains as to whether there is a direct link between the 
seasonality of influenza and vitamin D deficiency. Higher 
influenza incidence in winter may be due to behavioural 
reasons including the greater time spent indoors, which 
increases individuals’ proximity and hence likely inter-
personal transmission. Nonetheless, vitamin D appears 
to inhibit pulmonary inflammatory responses25 while 
enhancing innate defence mechanisms against respira-
tory pathogens.26 Moreover, population- based studies 
show positive associations between circulating 25OHD 
concentration and lung function.27 Nevertheless, formal 
systematic reviews/meta- analyses of these associations are 
urgently required.
URTIs, or ‘common colds’, are the most widespread of 
infectious diseases, with more than 200 viruses contrib-
uting to the clinical symptoms. Epidemiological studies 
in children have found a strong association between 
URTI and rickets.28 A large cross- sectional study of the 
US population reported that URTI infections were higher 
in those with lower vitamin D status, with the association 
being stronger in those with respiratory diseases such 
as asthma and chronic obstructive pulmonary disease.29 
There is evidence that lower vitamin D status is associ-
ated with acute respiratory tract infections (ARTIs).30 
In a recent systematic review and meta- analysis of indi-
vidual participant data from vitamin D supplementation 
RCTs, vitamin D supplementation reduced the risk of 
ARTI, with the greatest benefit in those with vitamin D 
deficiency at baseline.31 However, it is important to note 
the limitations to this systematic review/meta- analysis;32 33 
there was a high level of heterogeneity in the findings 
and concomitantly, the overall significant results in the 
meta- analysis of the 24 included trials was dependent on 
the inclusion of the two studies undertaken in developing 
countries: Mongolia and Afghanistan. These two trials 
had specific participants and the findings should not be 
extrapolated to populations from more developed coun-
tries. This is particularly important as Panagiotou et al 
(2013) demonstrated that the efficacy of many treatments 
was substantially greater in less developed compared with 
more developed countries.34 Furthermore, the specific 
clinical definitions of ARTI were varied across included 
studies, with many research participants with ARTI being 
self- diagnosed.
viTamin d, sars-Cov-2 virus and Covid-19 disease
The continued spread of the novel SARS- CoV-2 virus, and 
the disease COVID-19 that is caused by SARS- CoV-2, has 
led to calls for widespread high- dose vitamin D supple-
mentation.35–39 These calls are without support from 
pertinent studies in humans at this time, but rather 
based on speculations about presumed mechanisms. 
There have been two key studies published to support 
this presumption: (1) An unbiased screen of repurposed 
drugs for treatment of avian influenza A H5N1 virus 
using appropriate cell lines and mice, which highlighted 
calcitriol (the active hormone of vitamin D) as a poten-
tial therapy.40 (2) A recent analysis of vitamin D and viral 
infections.41 However, whether these mechanisms apply 
with SARS- CoV-2 is not known. Studies investigating 
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vitamin D and COVID-19 are currently underway,42 43 and 
more are likely to follow. Given that ethnic minorities 
are disproportionately affected with Covid-19—and this 
appears to be the case principally in the UK, the USA and 
other European countries—further research is justified, 
especially given that there is clear evidence that vitamin 
D deficiency is particularly common in these ethnic 
groups.44 45
However, we strongly caution against doses higher 
than the upper limit (4000 IU/day; 100 µg/day);7 8 
and certainly of very high doses of vitamin D (in some 
reports, 10 000 IU/day (250 µg/day) of vitamin D are 
being promoted) unless under personal medical advice/
clinical advice by a qualified health professional. Instead, 
we advocate the following lifestyle strategies for avoiding 
vitamin D deficiency and ensuring a healthy, balanced 
diet.
viTamin d adviCe
Current evidence- based advice for the prevention of 
vitamin D deficiency includes:
1. Supplementation with vitamin D according to Government 
guidelines (eg, 400 IU/day (10 µg/day) for the UK;7 600 
IU/day (15 µg/day) for the USA8 (800 IU/day (20 µg/
day) for >70 years) and Europe.9 These recommenda-
tions were established to ensure that 25OHD concen-
trations in the majority of the population are above 
25 nmol/L (UK) in order to protect musculoskeletal 
health or above 30 nmol/L (USA) to minimise the 
risk of vitamin D deficiency (the USA recommenda-
tion was also established to optimise musculoskeletal 
health in the population using a 25OHD concentra-
tion of 50 nmol/L). Supplementation with vitamin D 
is particularly important during times of self- isolation 
associated with limited sunlight exposure. This is in 
line with the UK Scientific Advisory Committee on 
Nutrition (SACN)7 recommendations for vitamin D, 
and the US Institute of Medicine (IOM) recommen-
dations for vitamin D,8 both of which were established 
under the assumption of minimal exposure to sun-
light. Thus, re- emphasis of advice on safe sun expo-
sure (below) and reinforcing government advice on 
supplements especially when sunlight exposure is low 
would further boost vitamin D status. The UK SACN, 
US IOM and EU European Food Safety Agency rec-
ommend that vitamin D intake (total from both foods 
and dietary supplements) should be limited to 4000 
IU/day (100 µg/day) for adults, and there is broad in-
ternational consensus that the general public should 
avoid higher dose supplements that risk total intake 
from all sources exceeding this level.
2. Consumption of a nutritionally balanced diet, for example, 
according to the UK Eatwell Guide46 and US Food Pyr-
amid47 including vitamin D rich foods, that is, oily fish, 
red meat, egg yolk and fortified foods,48 such as break-
fast cereals in the UK, as well as fortified milk in the 
USA and Canada.49 50
3. Safe sunlight exposure to boost vitamin D status. Safe sun-
light exposure will enable vitamin D production in 
skin from March through September in the UK, and at 
most northern latitudes. Dermal synthesis of vitamin D 
is most efficient with short, regular (daily) exposures 
when the sun is at its strongest (in the middle of the 
day).51 The efficiency of vitamin D synthesis declines 
well before the threshold for sunburn is reached12 but 
the desirable dose is skin- type dependent and so ex-
posure times required differ for different skin types.52 
For the UK about 10 min of exposure at around lunch-
time, in- season appropriate clothing, can meet vitamin 
D needs for white- skinned people; this increases to 
about 25 min for those of skin type V (ie, South Asian, 
brown skin tones).53 54 What is key is to try to achieve 
the sunlight exposure without leaving home (eg, in 
the garden/balcony); and if that is not possible ensure 
that social distancing is maintained at all times. In-
creasing the unprotected skin area (skin not protected 
by clothing or sunscreen) will increase the vitamin D 
supply from skin while keeping exposure times short 
and suberythemal. Exposing as much skin as tempera-
ture and social comfort allow will maximise vitamin D 
supply through this route. For those of skin type V and 
VI (brown or black skin) the exposure requirements 
in UK sunlight are more challenging to achieve than 
for white- skinned people and oral vitamin D intake is 
especially important.
4. Appropriate diet and lifestyle measures, as emphasised by 
the WHO at this time, including adequate nutrition to 
protect the immune system.55
5. Targeted nutritional advice, for example, for UK Military 
personnel as advised by the Defence Nutrition Adviso-
ry Service, with specific reference to COVID-19.56
6. Vitamin D—advice for bone health. The Royal Osteoporosis 
Society provides specific guidelines on the manage-
ment of vitamin D deficiency in adults with, or at risk 
of developing, bone disease.57
In conclusion, we recommend appropriate vitamin D 
RCTs to evaluate the effects of vitamin D supplementation 
on COVID-19 infections. Until there is more robust scien-
tific evidence for vitamin D, we strongly caution against 
the use of high vitamin D supplementation (greater than 
the upper limit of 4000 IU/day (100 µg/day)). Rather, 
we strongly endorse avoidance of vitamin D deficiency58 
in the population (as per the six points above) and 
complete adherence to government’s advice worldwide 
on the prevention of the spread of COVID-19.
summary for soCial media
Vitamin D is essential for good health, especially bone 
and muscle health. Many people have low blood levels 
of vitamin D, especially in winter or if confined indoors, 
because summer sunshine is the main source of vitamin 
D for most people. Government vitamin D intake recom-
mendations for the general population are 400 IU (10 µg) 
per day for the UK7 and 600 IU (15 µg) per day for the 
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USA8 (800 IU (20 µg) per day for >70 years) and the EU.9 
Taking a daily supplement (400 IU /day (10 µg/day) in 
the UK) and eating foods that provide vitamin D is partic-
ularly important for those self- isolating59 with limited 
exposure to sunlight. Vitamin D intakes greater than the 
upper limit of 4000 IU (100 µg) per day may be harmful 
and should be avoided unless under personal medical/
clinical advice by a qualified health professional.
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